Article Archive: Damien Conover, CFA

Title Collection Author Date
Pfizer Posts Strong Q1 Buoyed by COVID-19 Sales Stock Analyst Update Damien Conover, CFA 05/04/21
AbbVie Posts Solid Q1 Stock Analyst Update Damien Conover, CFA 04/30/21
Merck Posts Soft Q1 Pressured by COVID-19 Headwinds Stock Analyst Update Damien Conover, CFA 04/29/21
J&J Buoyed by Elective Procedures, Cancer Drug Sales Stock Analyst Update Damien Conover, CFA 04/20/21
J&J's COVID-19 Vaccine Shows Rare Events, Now Paused Stock Analyst Update Damien Conover, CFA 04/13/21
Drugmakers and Managed-Care Firms Are Poised for Growth US Videos Damien Conover, CFA 04/08/21
Drugmakers and Managed-Care Firms Still Look Undervalued Quarter-End Insights Damien Conover, CFA 04/01/21
BioNTech Reports Solid Fourth-Quarter Results Stock Analyst Update Damien Conover, CFA 03/30/21
AstraZeneca Reports Good Confirmatory Vaccine Data Stock Analyst Update Damien Conover, CFA 03/25/21
Astra Posts Solid U.S. Phase 3 Data for Vaccine Stock Analyst Update Damien Conover, CFA 03/22/21
JNJ's COVID-19 Vaccine Receives FDA Authorization Stock Analyst Update Damien Conover, CFA 02/28/21
AstraZeneca's Growth Outlook Continues to Look Strong Stock Analyst Update Damien Conover, CFA 02/11/21
Merck Posts Steady Q4; CEO Ken Frazier to Retire Stock Analyst Update Damien Conover, CFA 02/04/21
AbbVie Posts Strong Q4 and Issues Robust 2021 Guidance Stock Analyst Update Damien Conover, CFA 02/03/21
Pfizer Vaccine Shows Promise for Huge Near-Term Growth Stock Analyst Update Damien Conover, CFA 02/02/21
J&J Posts Solid Q4 and Issues Favorable 2021 Guidance Stock Analyst Update Damien Conover, CFA 01/26/21
Biopharma Companies With COVID-19 Treatments See $10 Billion Market in 2021 Stock Strategist Industry Reports Damien Conover, CFA 01/19/21
Healthcare Outlook: Coronavirus at Center Stage US Videos Damien Conover, CFA 01/11/21
In Healthcare, Drugmakers and Managed-Care Firms Look Attractive Quarter-End Insights Damien Conover, CFA 01/05/21
Eli Lilly Provides Strong Outlook and Positive Updates Stock Analyst Update Damien Conover, CFA 12/16/20
FDA Supports EUA for Pfizer-BioNTech’s COVID-19 Vaccine Stock Analyst Update Damien Conover, CFA 12/13/20
Implementation of Trump's Drug-Pricing Orders Unlikely Stock Strategist Industry Reports Damien Conover, CFA 11/24/20
Astra and Oxford Report Strong COVID-19 Vaccine Stock Analyst Update Damien Conover, CFA 11/23/20
Pfizer/BioNTech Report 95% Efficacy Rate for Vaccine Stock Analyst Update Damien Conover, CFA 11/18/20
Pfizer and BioNTech Report Strong COVID-19 Vaccine Data Stock Analyst Update Damien Conover, CFA 11/09/20
Election Seems to Ease Concerns on Drug Pricing Changes Stock Analyst Update Damien Conover, CFA 11/06/20
AbbVie Posts Strong Q3, Buoyed by New Immunology Drugs Stock Analyst Update Damien Conover, CFA 10/30/20
Pfizer Faces Modest Pressures in Q3 Stock Analyst Update Damien Conover, CFA 10/27/20
Merck Posts Strong Third Quarter Stock Analyst Update Damien Conover, CFA 10/27/20
Bayer’s Announced Acquisition Adds Needed Boost Stock Analyst Update Damien Conover, CFA 10/26/20
Despite Pausing Drug Trials, J&J Reports Strong Quarter Stock Analyst Update Damien Conover, CFA 10/13/20
Healthcare Sector Adjusts to Pandemic's Pressures US Videos Damien Conover, CFA 10/09/20
Drugmakers, Managed-Care Firms Undervalued Quarter-End Insights Damien Conover, CFA 10/05/20
AstraZeneca's Pause on Vaccine Raises Uncertainty Stock Analyst Update Damien Conover, CFA 09/09/20
J&J Strengthens Pipeline With Momenta Acquisition Stock Analyst Update Damien Conover, CFA 08/19/20
Pandemic Headwinds Pressure AbbVie’s Second Quarter Stock Analyst Update Damien Conover, CFA 07/31/20
Innovation Supports Growth at Big Pharma/Big Biotech Companies Stock Strategist Industry Reports Damien Conover, CFA 07/30/20
Pfizer Posts Slightly Better-Than-Expected Q2 Stock Analyst Update Damien Conover, CFA 07/28/20
Drug Pricing Executive Orders Not Likely to Affect FVEs Stock Analyst Update Damien Conover, CFA 07/27/20
Wide-Moat J&J Posts Better-Than-Expected Q2 Stock Analyst Update Damien Conover, CFA 07/16/20
3 Reasons Healthcare Is Showing Fit Performance US Videos Damien Conover, CFA 07/02/20
Healthcare Sector Less Appealing After Market Rebound Quarter-End Insights Damien Conover, CFA 06/30/20
Bayer Settlement Leads to Fair Value Estimate Decrease Stock Analyst Update Damien Conover, CFA 06/24/20
Positive Data Boosts Outlook for Lilly Stock Strategist Damien Conover, CFA 06/16/20
Undervalued Pfizer Remains Poised for Growth Stock Strategist Damien Conover, CFA 06/09/20
J&J Halts Talc Powder Sales in U.S. and Canada Stock Analyst Update Damien Conover, CFA 05/20/20